Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Titel:
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Auteur:
Mastellos, Dimitrios C. Pires da Silva, Bruno G.P. Fonseca, Benedito A.L. Fonseca, Natasha P. Auxiliadora-Martins, Maria Mastaglio, Sara Ruggeri, Annalisa Sironi, Marina Radermacher, Peter Chrysanthopoulou, Akrivi Skendros, Panagiotis Ritis, Konstantinos Manfra, Ilenia Iacobelli, Simona Huber-Lang, Markus Nilsson, Bo Yancopoulou, Despina Connolly, E. Sander Garlanda, Cecilia Ciceri, Fabio Risitano, Antonio M. Calado, Rodrigo T. Lambris, John D.